Complement inhibition in severe COVID-19 - Blocking C5a seems to be key

EClinicalMedicine. 2021 Apr 24:35:100722. doi: 10.1016/j.eclinm.2021.100722. eCollection 2021 May.

¹ Department of Intensive Care Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam UMC, 1100DD Amsterdam, the Netherlands.
² Department of Neurology, Amsterdam Neuroscience, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

No abstract available